| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |